Objective: Iliofemoral endarterectomy with external iliac artery (EIA) stent grafting can be an alternative to traditional open surgery in patients with severe iliac occlusive disease extending to the common femoral artery. We report the midterm outcomes of this approach.
Although endovascular repair of the common femoral artery (CFA) has been described, 1 open repair of the CFA remains the treatment classically used in patients with isolated occlusive disease. 2, 3 Surgical repair of the CFA avoids the risk of stent fracture and does not compromise future surgical or endovascular options. Treatment is not consensual for lesions extending proximally into the external iliac arteries (EIAs). 4 Guidelines from the TransAtlantic Inter-Society Consensus II (TASC II) recommend open surgical bypass for TASC C and D lesions (Table I) , with consideration of endovascular options for only TASC C lesions in good-risk patients. 5 Surgical options, including iliofemoral endarterectomy and aortofemoral bypass, have been reported to be durable but may be associated with higher perioperative morbidity and mortality and late complication rates according to the literature. 6, 7 Axillofemoral bypass and interfemoral bypass, less invasive but also less durable, are generally reserved for frail and high-risk patients. 8 Chang et al reported their results of combined CFA endarterectomy and iliac stenting, with acceptable long-term patency and higher primary patency rates in the subgroup with covered stents. 9 It would be interesting to focus on the specific results of combined CFA endarterectomy and systematic EIA stent grafting in good-risk patients. The aim of this study was to report long-term outcomes of a hybrid approach combining iliofemoral endarterectomy and systematic EIA stent grafting for the treatment of severe iliofemoral occlusive disease. 
METHODS
The study was approved by the Institutional Review Board and was conducted in accordance with the Declaration of Helsinki. Informed consent requirements were waived for this retrospective study.
Inclusion and follow-up. Between January 2009 and December 2015, all patients treated at Amiens University Hospital by CFA endarterectomy and EIA stent grafting for repair of severe iliofemoral occlusive disease were consecutively included. Data were collected retrospectively.
All patients underwent preoperative physical examination and were evaluated by duplex ultrasound (DUS) and contrast-enhanced computed tomography (CT). These two examinations provided both hemodynamic and morphologic analysis of the vessel and guided the operative strategy. Patients with significant EIA occlusive disease (thrombosis or severe extensive stenosis) extending into the CFA were considered for hybrid treatment. Patients with extensive occlusive disease involving the common iliac artery (CIA) or aorta were also included. Patients were regularly reviewed with 1-month, 6-month, and annual clinical and DUS follow-up. A localized peak systolic velocity increase of >2.5 times was considered evidence for recurrent stenosis. Repeated surgery was performed after CT angiography or digital subtraction angiography according to the surgeon's usual practice. CT angiography or digital subtraction angiography showing luminal narrowing >50% was considered evidence of restenosis.
Operative technique. Femoral artery exposure was obtained by a curved groin incision under general anesthesia. In patients with extensive EIA stenosis, CFA or superficial femoral artery (SFA) puncture was first performed to provide guidewire access across the iliac lesion into the abdominal aorta under fluoroscopic guidance. If guidewire access could not be obtained initially, it was then attempted after endarterectomy. In the case of EIA thrombosis, recanalization was first attempted with antegrade wire access by crossing the aortic bifurcation through contralateral CFA puncture. Rarely, axillary or carotid artery access was used for patients with bilateral iliac occlusion.
CFA endarterectomy was then performed with the guidewire in place. When the femoral artery lesion did not extend far into the SFA and profunda femoris artery (PFA), endarterectomy was performed by eversion. After ligation of the superficial circumflex iliac artery and epigastric superficial artery and dissection of the EIA sparing the inguinal ligament as far as possible, oblique transection of the CFA was performed just above the femoral bifurcation. The eversion CFA endarterectomy was extended proximally as far as the EIA. The femoral bifurcation was then endarterectomized, ensuring preservation or restoration of adequate PFA and SFA outflows (Fig 1) . Direct suture was then performed using a 5-0 or 6-0 polypropylene suture. The posterior wall was reconstructed using the anchor or parachute anastomosis technique. Eversion endarterectomy could be correctly performed only when occlusive disease did not extend too far into the SFA or PFA. When eversion was not technically feasible, standard endarterectomy with direct suture or patch angioplasty was performed. When the arterial wall was too thin or torn, prosthetic femorofemoral bypass was performed.
After restoration of flow, a 9F short sheath was placed over the wire. The EIA was then predilated using a 6-or 7-mm-diameter angioplasty balloon according to the "paving and cracking" technique. The diameter of the self-expanding covered stent (Fluency; Bard, Tempe, Ariz) was calibrated to the diameter of the endarterectomized distal EIA (generally 8 mm in women and 10 mm in men), and the length of the lesion was measured with a marker catheter and fluoroscopy imaging software. The stent was generally deployed just beyond the origin of the internal iliac artery and covered the proximal portion of the endarterectomized segment. The stent was finally impacted by means of subsequent balloon dilation (Fig 2) . In the presence of an aortic or CIA lesion, these segments were treated first by aortoiliac stenting or stent grafting (Fig 3) . A patent internal iliac artery was preserved whenever possible. In rare cases, the internal iliac ostium was covered after ensuring the patency of the contralateral internal iliac artery.
Definitions. Technical success is defined as successful technique to re-establish vessel patency with a residual stenosis of <30%.
Primary patency refers to patency that is obtained without the need for additional or secondary surgical or endovascular procedures Assisted primary patency is patency achieved with the use of an additional or secondary surgical or endovascular procedure, as long as occlusion of the primary treated site has not occurred. Secondary patency is patency obtained with the use of an additional or secondary surgical or endovascular procedure after occlusion occurs. 10 Statistical analysis. All statistical analysis was performed using the statistical SAS package 9.2 for Windows (SAS Institute, Cary, NC). Results for continuous variables were expressed as mean 6 standard error of the mean and compared by the Mann-Whitney test or Student t-test, as appropriate. Categorical variables were expressed as a percentage and compared by the c 2 test.
Logistic regression was used to evaluate factors associated with failure of primary patency. Patency rates were calculated with the Kaplan-Meier method. Values of P < .05 were considered statistically significant.
RESULTS
Patient characteristics and imaging data. During the study period, 108 consecutive patients underwent hybrid procedures on 127 limbs. The study population was composed of 76% male patients with a median age of 63 years (range, 43-86 years) with a high incidence of hypertension and history of smoking. The median American Society of Anesthesiologists physical status classification was 2. Patient demographic data are detailed in Table II. The operative indication was claudication in 60% of cases, rest pain in 20% of cases, tissue loss in 15% of cases, and acute ischemia in 5% of cases. The indication for surgery in patients with claudication was severely disabling claudication. Thirty-day results. Iliofemoral endarterectomy was performed with the eversion technique in 80 (63%) cases, with direct suture in 13 (10%) cases and patch angioplasty in 29 (23%) cases. Short femorofemoral bypass was required in five (3%) cases because of a tear of the CFA wall. An average of 1.3 stents (range, 1-3) were used on the EIA segment. Fluency covered stents were used in all cases. Advanta V12 (Atrium Medical, Hudson, NH) covered stents were added in two cases of heavily calcified EIA following an insufficient result with the Fluency stent graft. The median stent diameter was 8 mm (range, 6-10 mm). The median length of EIA treated was 100 mm (range, 60-140 mm). Recanalization was performed through a retrograde approach in 72 (57%) cases and an anterograde approach in 55 (43%) cases, with a contralateral approach (crossover) in 49 (39%) cases and an axillary or carotid approach in 6 (5%) cases.
In 60% of cases, both EIA and CIA segments were treated, with aortobi-iliac stenting in 11% of cases.
The technical success rate was 100%. No immediate rupture or dissection was observed. Bilateral procedures were performed in 12 patients (11%) during the same operation. Seven (6%) concomitant femoropopliteal bypasses, five (4%) SFA stents, and one (1%) interfemoral bypass were performed. A distal endovascular intervention was performed in four (3%) cases.
There were no perioperative deaths, but 4 (3%) perioperative general complications (including 2 myocardial ischemic events, 1 pulmonary event, and 1 deep venous thrombosis) and 10 (8%) wound infections resolving with prolonged local care were observed. The median length of stay was 5 days (range, 3-11 days). Follow-up DUS was performed to confirm good patency of the repair in all patients before discharge. All patients were clinically improved after the procedure.
Four patients (3%) required early reintervention. Occlusion occurred after 8 days in a poorly compliant patient and was successfully thrombectomized by an open procedure. Vein patch angioplasty with repeated EIA stent grafting was performed. Local infection was treated by surgical débridement and negative pressure therapy in one patient at 10 days. One patient required redo surgery at 12 days because of bleeding due to suture dehiscence that was successfully treated with vein patch angioplasty. Repeated surgery was performed in one patient after 15 days because of patch infection with sepsis. Iliofemoral bypass was performed with venous material.
Follow-up. Median follow-up was 30 months (range, 0-6 years). Overall survival was 87%. Fourteen patients died during follow-up because of cancer in half of the cases.
Secondary percutaneous dilation with subsequent stenting was performed in three (2%) cases because of in-stent restenosis in two patients with no recurrent symptoms and CFA restenosis in one patient with recurrent claudication. A subsequent open procedure on the iliofemoral segment was performed in seven (5%) patients with recurrent symptoms (Table III) . Mean time to reoperation was 10 months.
Distal bypass or a distal endovascular procedure was performed in seven (5%) patients with more distal disease. Overall, three minor amputations and four major amputations were performed during follow-up in the study population. All patients requiring amputation presented with initial critical limb ischemia associated with ulcer or focal gangrene. Major amputations were Renal insufficiency 14 (13) performed because of major tissue loss with extensive gangrene. At 2 years, primary patency rate of the treated segment was 91%. Primary assisted patency and secondary patency rates at 2 years were 94% and 98%, respectively. Five-year primary, primary assisted, and secondary patency rates were 87%, 92%, and 98%, respectively (Fig 4) . No patient-related factors or lesion characteristics were found to be predictive of patency.
DISCUSSION
This study reports the results of the hybrid technique combining iliofemoral endarterectomy and concomitant EIA stent grafting for the treatment of severe occlusive disease.
Although surgical treatment is classically recommended for severe occlusive disease of the iliofemoral segment, endovascular approaches have become increasingly popular and are now widely used because of the minimally invasive approach with decreased surgical morbidity and decreased hospital and intensive care unit lengths of stay. 11, 12 Open repair, including aortobifemoral, aortofemoral, and iliofemoral bypass, can be associated with significant operative mortality, between 1% and 8% in published studies. 13, 14 Open surgery is also associated with systemic morbidity and local morbidity. 15, 16 Furthermore, late complications, including graft infection, anastomotic pseudoaneurysm, and reocclusion, are not rare and can be challenging to treat. 7, 17 No recent studies have reported the results of open surgery for occlusive disease. The extensive review by de Vries and Hunink (1997) showed that the mortality and systemic morbidity of open surgery appeared to be better in the more recent studies. 7 A few in-hospital complications were observed in our study. Wound infections were always observed in a context of obese diabetic patients and generally resolved with prolonged local care. In these patients, iliofemoral eversion was performed as often as possible to avoid the presence of prosthetic material in the groin. In addition, with the hybrid technique, male patients are not exposed to the risks of erectile dysfunction associated with open iliac or aortic surgery. Although the procedure was performed under general anesthesia in this series, it could also be performed under spinal, epidural, or regional anesthesia, which could improve tailored patient care. Late complication and reoperation rates were low. Patients who required redo surgery always presented with progressive extensive occlusive disease. Open reconstructions have overall 5-year primary patency rates between 80% and 95%. 7 Kashyap et al, in
2008, reported a 3-year overall primary patency rate for aortobifemoral bypass of 93% and a secondary patency rate of 97%. 11 Nelson et al reported a 1-year primary patency rate of 84% for CFA endarterectomy with EIA stenting using bare stents. 18 Chang et al, who reported the results of combined common femoral endarterectomy and iliac stenting or stent grafting, reported a 5-year primary patency rate of 60%, with a primary assisted patency rate of 97% and a secondary patency rate of 98% for TASC C and D lesions. The use of stent grafts compared with bare stents was associated with improved primary patency. 9 In our study, 5-year primary, primary assisted, and secondary patency rates were 87%, 92%, and 98%, respectively, comparable to the results of open surgical repair. It is noteworthy that previous publications comprised a higher proportion of patients with critical limb ischemia than patients with claudication. 9, 18 The high proportion of patients with claudication in this study may therefore have had an impact on patency outcomes, although no patient symptom was found to be statistically predictive of patency. Angioplasty of the CFA has been described with encouraging technical and clinical results. 19, 20 because of technical difficulties related to the treatment of complex lesions involving the femoral bifurcation and the risk of stent fracture during hip joint flexion. Significant restenosis rates have also been reported, ranging between 15% and 28%. 19, 22 The most important point is that CFA stenting prevents future femoral artery puncture. In contrast, iliofemoral endarterectomy with EIA stent grafting allows future procedures to ensure patency of the iliofemoral segment but also to treat cardiac, supra-aortic, or aortic disease. Some technical issues need to be discussed. Contrary to Chang et al, who reported femoral endarterectomy and patch angioplasty, 9 we performed iliofemoral endarterectomy by eversion whenever possible. This technique avoids potential prosthetic material infection, especially in obese, diabetic, or immunocompromised patients. Ligation of both the superficial circumflex iliac artery and the superficial epigastric artery allows the eversion endarterectomy to be extended under the inguinal ligament. The stent graft covers the proximal endarterectomy without extending into the hip joint. The EIA segment was either massively calcified or completely occluded (TASC C and D lesions, Table I ). Recanalization can be performed through a retrograde approach or an anterograde approach (with the crossover technique through the contralateral artery or through an axillary approach). Experience has shown that retrograde recanalization of the EIA after femoral endarterectomy can be technically difficult and timeconsuming and that it is preferable to establish wire access to the iliac segment before femoral endarterectomy. We prefer first-line puncture of the CFA or the SFA to obtain wire access to the iliac segment, followed by endarterectomy. Moreover, it can sometimes be difficult to re-enter the CIA true lumen after retrograde EIA recanalization. We have observed that antegrade recanalization is easier in the case of complete occlusion. This approach (through the contralateral femoral artery or through the supra-aortic vessels) allows the guidewire to be retrieved through the endarterectomy.
Covered stents were systematically used for the EIA. The stent graft was calibrated to the diameter of the endarterectomized distal EIA. We think that the use of covered stents allows a gain of at least 2 mm in diameter compared with bare-metal stents and resolves the potential periprocedural problems of arterial dissection or rupture. A large-diameter iliac stent graft, or iliac "endo-bypass," should ensure satisfactory long-term patency results, and we believe that the distal end point of the stent graft must cover the proximal edge of the endarterectomy to compress the intimal flap against the arterial wall and decrease the risk of late restenosis.
This study is limited by its retrospective and singlecenter design, with a potential selection bias. Nevertheless, this is the largest series to date evaluating the long-term results of the specific technique combining femoral endarterectomy with EIA stent grafting in the management of severe occlusive disease.
CONCLUSIONS
The technical and clinical outcomes in this series suggest that the hybrid technique combining iliofemoral endarterectomy and EIA stent grafting is a feasible and effective treatment for severe occlusive disease. Longer follow-up in larger populations will confirm the durable results of this procedure.
